{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T17:36:06Z","timestamp":1715967366570},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s11940-005-0050-y","type":"journal-article","created":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T12:07:24Z","timestamp":1182946044000},"page":"499-511","source":"Crossref","is-referenced-by-count":3,"title":["New treatments in acute ischemic stroke"],"prefix":"10.1007","volume":"7","author":[{"given":"Michael J.","family":"Schneck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Biller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"50_CR1","unstructured":"Heart Disease and Stroke Statistics-2005 Update. Dallas, IX: American Heart Association; 2005. An excellent resource for stroke epidemiology data."},{"key":"50_CR2","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995,333:1581\u20131587. The foundation for modern acute stroke therapy (see Ingall et al. [4] and Hacke et al. [5] for elaboration).","journal-title":"N Engl J Med"},{"key":"50_CR3","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.324.7339.723","volume":"324","author":"J Lenzer","year":"2002","unstructured":"Lenzer J, Warlow C, Saver JL, et al.: Alteplase for stroke: money and optimistic claims buttress the \u201cbrain attack\u201d campaign (commentary); Thrombolysis in stroke: it works (commentary). BMJ 2002, 324:723\u2013729. A fascinating debate, although somewhat of a polemic on the part of the critics of tPA.","journal-title":"BMJ"},{"key":"50_CR4","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/01.STR.0000140891.70547.56","volume":"35","author":"TJ Ingall","year":"2004","unstructured":"Ingall TJ, O\u2019Fallon WM, Asplund K, et al.: Findings from the reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemie Stroke Trial. Stroke 2004, 35:2418\u20132424. Important for awareness of the current issues related to study that provides the foundation for modern acute stroke therapy[2] and the study by Lenzer et al. [3].","journal-title":"Stroke"},{"key":"50_CR5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","volume":"363","author":"W Hacke","year":"2004","unstructured":"Hacke W, Donnan G, Fieschi C, et al.: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS and NINDS rt-PA stroke trials. Lancet 2004, 363:768\u2013774. Highlights the importance of early stroke treatment.","journal-title":"Lancet"},{"key":"50_CR6","first-page":"CD00213","volume":"2","author":"JM Wardlaw","year":"2000","unstructured":"Wardlaw JM, del Zoppo G, Yamaguchi T, et al.: Thrombolysis for ischemie stroke. Cochrane Database Syst Rev 2000, 2:CD00213; Update in Cochrane Database Syst Rev 2003, 3:CD000213.","journal-title":"Cochrane Database Syst Rev"},{"key":"50_CR7","doi-asserted-by":"crossref","unstructured":"Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991, 325:445-453.","DOI":"10.1056\/NEJM199108153250701"},{"key":"50_CR8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1212\/WNL.50.4.883","volume":"50","author":"S Fagan","year":"1998","unstructured":"Fagan S, Morgenstern L, Petitta A, et al.: Cost-effectiveness of tissue plasminogen activator for acute ischemie stroke. Neurology 1998, 50:883\u2013890.","journal-title":"Neurology"},{"key":"50_CR9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.283.9.1151","volume":"283","author":"IL Katzan","year":"2000","unstructured":"Katzan IL, Furlan AJ, Lloyd LE: Use of tissue-type plasminogen activator for acute ischemie stroke: the Cleveland area experience. JAMA 2000, 283:1151\u20131158.","journal-title":"JAMA"},{"key":"50_CR10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.STR.0000056944.42686.1E","volume":"34","author":"IL Katzan","year":"2003","unstructured":"Katzan IL, Hammer MD, Furlan AJ, et al.: Quality improvement and tissue-type plasminogen activator for acute ischemie stroke. Stroke 2003, 34:799\u2013800. Evidence of the success of quality improvement programs for stroke.","journal-title":"Stroke"},{"key":"50_CR11","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1001\/jama.283.23.3102","volume":"283","author":"MJ Alberts","year":"2000","unstructured":"Alberts MJ, Hademenos G, Latchaw RE, et al.: Recommendations for the establishment of primary stroke centers. JAMA 2000, 283:3102\u20133109. Highlights the creation of organized stroke systems.","journal-title":"JAMA"},{"key":"50_CR12","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/01.STR.0000170622.07210.b4","volume":"36","author":"MJ Alberts","year":"2005","unstructured":"Alberts MJ, Latchaw RE, Selman WR, et al.: Recommendations for comprehensive stroke centers. A consensus statement from the Brain Attack Coalition. Stroke 2005, 36:1597\u20131616. Highlights the creation of organized stroke systems.","journal-title":"Stroke"},{"key":"50_CR13","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.STR.0000066309.06490.B8","volume":"34","author":"D Ramsey","year":"2003","unstructured":"Ramsey D, Smithard DG, Kalra L: Early assessments of dysphagia and aspiration risk in acute stroke patients. Stroke 2003, 34:1252\u20131257.","journal-title":"Stroke"},{"key":"50_CR14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.STR.0000063373.70993.CD","volume":"34","author":"R Hilker","year":"2003","unstructured":"Hilker R, Poetter C, Findeisein N, et al.: Nosocomial pneumonia after acute stroke. Implications for neurological intensive care medicine. Stroke 2003, 34:975\u2013981.","journal-title":"Stroke"},{"key":"50_CR15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-130-1-199901050-00004","volume":"130","author":"GW Petty","year":"1999","unstructured":"Petty GW, Brown RD Jr, Whisnant JP, et al.: Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention: a population-based study. Ann Intern Med 1999, 130:14\u201322.","journal-title":"Ann Intern Med"},{"key":"50_CR16","doi-asserted-by":"crossref","unstructured":"The International Stroke Trial (IS): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997, 349:1569-1581.","DOI":"10.1016\/S0140-6736(97)04011-7"},{"key":"50_CR17","doi-asserted-by":"crossref","unstructured":"CAST: randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 1997, 349:1641-1649.","DOI":"10.1016\/S0140-6736(97)04010-5"},{"key":"50_CR18","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","volume":"31","author":"ZM Chen","year":"2000","unstructured":"Chen ZM, Sandercock P, Han HC, et al.: Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups. Stroke 2000, 31:1240\u20131249.","journal-title":"Stroke"},{"key":"50_CR19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-8703(99)70118-3","volume":"138","author":"JS Hochman","year":"1999","unstructured":"Hochman JS, Wali AU, Gavrila D, et al.: A new regimen for heparin use in acute coronary syndromes. Am Heart J 1999, 138:313\u2013318.","journal-title":"Am Heart J"},{"key":"50_CR20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.STR.0000047036.77466.E8","volume":"34","author":"LR Caplan","year":"2003","unstructured":"Caplan LR: Resolved: heparin may be useful in selected patients with brain ischemia. Stroke 2003, 34:230\u2013231. Emphasizes the lack of data regarding a therapy still widely used but with limited clinical evidence.","journal-title":"Stroke"},{"key":"50_CR21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/01.STR.0000047037.38062.24","volume":"34","author":"P Sandercock","year":"2003","unstructured":"Sandercock P: Full heparin anticoagulation should not be used in acute ischemic stroke. Stroke 2003, 34:231\u2013232. Emphasizes the lack of data regarding a therapy still widely used but with limited clinical evidence.","journal-title":"Stroke"},{"key":"50_CR22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.STR.0000047038.86782.30","volume":"34","author":"GA Donnan","year":"2003","unstructured":"Donnan GA, Davis SM: Heparin in stroke: not for most, but the controversy lingers. Stroke 2003, 34:232\u2013233. Emphasizes the lack of data regarding a therapy still widely used but with limited clinical evidence.","journal-title":"Stroke"},{"key":"50_CR23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1159\/000086100","volume":"19","author":"A Chamorro","year":"2005","unstructured":"Chamorro A, Busse O, Obach V, et al.: The Rapid Anticoagulation Prevents Ischemie Damage (RAPID) study in acute stroke. Cerebrovasc Dis 2005, 19:402\u2013404.","journal-title":"Cerebrovasc Dis"},{"key":"50_CR24","doi-asserted-by":"crossref","unstructured":"Hankey GJ, Counsell C, Sandercock P: Low molecular weight heparins or heparinoids versus standard unfractionated heparin for acute ischemie stroke. The Cochrane Library 2002, 2.","DOI":"10.1002\/14651858.CD000119"},{"key":"50_CR25","doi-asserted-by":"crossref","unstructured":"Low molecular weight heparinoid, ORG 10172 (danaparoid) and outcome after ischemic stroke. A randomized controlled trial. TOAST Investigators. J Am Med Assoc 1998, 279:1265-1272.","DOI":"10.1001\/jama.279.16.1265"},{"key":"50_CR26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1212\/WNL.53.1.122","volume":"53","author":"HP Adams","year":"1999","unstructured":"Adams HP Jr, Bendixine BH, Leira E, et al.: Antithrombotic treatment of ischemie stroke among patients with occlusion or severe stenosis of the internal carotid artery: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999, 53:122\u2013125.","journal-title":"Neurology"},{"key":"50_CR27","first-page":"208","volume":"51","author":"GR Sarma","year":"2003","unstructured":"Sarma GR, Roy AK: Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke. Neurol India 2003, 51:208\u2013210.","journal-title":"Neurol India"},{"key":"50_CR28","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM199512143332402","volume":"333","author":"R Kay","year":"1995","unstructured":"Kay R, Wong KS, Yu YL, et al.: Low molecular weight heparin for the treatment of acute ischemie stroke. N Engl J Med 1995, 333:1588\u20131593.","journal-title":"N Engl J Med"},{"key":"50_CR29","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.STR.0000064841.47697.22","volume":"34","author":"HP Adams","year":"2003","unstructured":"AdamsHP Jr, Adams RJ, Brott T, et al.: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34:1056\u20131083. Important summary statement about acute stroke therapy.","journal-title":"Stroke"},{"key":"50_CR30","doi-asserted-by":"crossref","unstructured":"Intracerebral hemorrhage after intravenous tPA therapy for ischemic stroke. The NINDS TPA Stroke Study Group. Stroke 1997, 28:2109-2118.","DOI":"10.1161\/01.STR.28.11.2109"},{"key":"50_CR31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.STR.0000154872.73240.e9","volume":"36","author":"EC Haley","year":"2005","unstructured":"Haley EC Jr, Lyden PD, Johnston KC, et al.: A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke 2005, 36:607\u2013612.","journal-title":"Stroke"},{"key":"50_CR32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","volume":"36","author":"W Hacke","year":"2005","unstructured":"Hacke W, Albers G, Al-Rawi Y, et al.: The Desmoteplase in Acute Ischemie Stroke Trial (DIAS): a phase II MRI-based 9 hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36:66\u201373. Important study that is one of the first stroke studies to determine enrollment based on imaging criteria.","journal-title":"Stroke"},{"key":"50_CR33","doi-asserted-by":"crossref","unstructured":"Emergency administration of abciximab for treatment of patients with acute ischemie stroke. Results of a randomized phase 2 trial. Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators. Stroke 2005, 36:880-890. A therapy representing an alternative intravenous strategy to tPA.","DOI":"10.1161\/01.STR.0000157668.39374.56"},{"key":"50_CR34","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1161\/01.STR.0000131549.20581.ba","volume":"35","author":"MP LaMonte","year":"2004","unstructured":"LaMonte MP, Nash ML, Wang DZ, et al.: Argatroban anticoagulation in patients with acute ischemie stroke (ARGIS-1): a randomized placebo-controlled safety study. Stroke 2004, 35:1677\u20131682.","journal-title":"Stroke"},{"key":"50_CR35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ana.10407","volume":"53","author":"M Fisher","year":"2003","unstructured":"Fisher M, Ratan R: New perspectives on developing acute stroke therapy. Ann Neurol 2003, 53:10\u201320.","journal-title":"Ann Neurol"},{"key":"50_CR36","doi-asserted-by":"crossref","unstructured":"Magnesium for acute stroke. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Lancet 2004, 363:439-445.","DOI":"10.1016\/S0140-6736(04)15490-1"},{"key":"50_CR37","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/01.STR.0000124458.98123.52","volume":"35","author":"JL Saver","year":"2004","unstructured":"Saver JL, Kidwell C, Eckstein M, et al.: Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 2004, 35:106\u2013108. Another alternative intravenous strategy to tPA, highlighting the importance of ultra-rapid treatment.","journal-title":"Stroke"},{"key":"50_CR38","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","volume":"282","author":"A Furlan","year":"1999","unstructured":"FurlanA, Higashida R, Wechsler L, et al.: Intra-arterial prourokinase for acute ischemie stroke. The PROACT II Study: a randomized clinical trial. JAMA 1999, 282:2003\u20132011. The landmark study of intra-arterial therapy.","journal-title":"JAMA"},{"key":"50_CR39","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/01.STR.32.6.1365","volume":"32","author":"JA Chalela","year":"2001","unstructured":"Chalela JA, Katzan I, Liebeskind DS, et al.: Safety of intra-arterial thrombolysis in the post-operative period. Stroke 2001, 32:1365\u20131369.","journal-title":"Stroke"},{"key":"50_CR40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.STR.0000125711.94465.78","volume":"35","author":"SR Ramee","year":"2004","unstructured":"Ramee SR, Subramanian R, Felberg RA, et al.: Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis. Stroke 2004, 35:109\u2013111.","journal-title":"Stroke"},{"key":"50_CR41","doi-asserted-by":"crossref","unstructured":"Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke (IMS) Study. IMS Study Investigators. Stroke 2004, 35:904-911.","DOI":"10.1161\/01.STR.0000121641.77121.98"},{"key":"50_CR42","first-page":"41","volume":"49","author":"AI Qureshi","year":"2001","unstructured":"Qureshi AI, Ali Z, Suri MF, et al.: Intra-arterial third generation recombinant tissue plasminogen activator (reteplase) for acute ischemie stroke. Neurosurgery 2001, 49:41\u201348.","journal-title":"Neurosurgery"},{"key":"50_CR43","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/jnnp.2003.020479","volume":"75","author":"M Arnold","year":"2004","unstructured":"Arnold M, Nedeltchev K, Schroth G, et al.: Clinical and radiological predictors of recanalization and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. \/ Neurol Neurosurg Psychiatr 2004, 75:857\u2013862. Evidence that the time-window for thrombolytic therapy is not uniform.","journal-title":"Neurol Neurosurg Psychiatr"},{"key":"50_CR44","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0749-0704(05)70084-1","volume":"15","author":"TG Phan","year":"1999","unstructured":"Phan TG, Wijdicks EF: Intra-arterial thrombolysis for vertebrobasilar circulation ischemia. Crit Care Clin 1999, 15:719\u2013742.","journal-title":"Crit Care Clin"},{"key":"50_CR45","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1161\/01.STR.0000147718.12954.60","volume":"35","author":"YP Gobin","year":"2004","unstructured":"Gobin YP, Starkman S, Duckwiler S, et al.: MERCI 1: a phase one study of mechanical embolus removal in cerebral ischemia. Stroke 2004, 35:2848\u20132853.","journal-title":"Stroke"},{"key":"50_CR46","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.STR.0000171066.25248.1d","volume":"36","author":"WS Smith","year":"2005","unstructured":"Smith WS, Sung G, Starkman S, et al.: Safety and efficacy of mechanical embolectomy in acute ischemie stroke. Results of the MERCI trial. Stroke 2005, 36:1432\u20131438. An interesting single-arm study.","journal-title":"Stroke"},{"key":"50_CR47","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1056\/NEJMoa041175","volume":"351","author":"AV Alexandrov","year":"2004","unstructured":"Alexandrov AV, Molina CA, Grotta JC, et al.: Ultra-sound-enhanced systemic thrombolysis for acute ischemie stroke. N Engl J Med 2004, 351:2170\u20132178. An interesting application of noninvasive and portable technology in conjunction with standard drug therapies.","journal-title":"N Engl J Med"},{"key":"50_CR48","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1056\/NEJMp048249","volume":"351","author":"JF Polak","year":"2004","unstructured":"Polak JF: Ultrasound energy and the dissolution of thrombus. N Engl J Med 2004, 351:2154\u20132155.","journal-title":"N Engl J Med"},{"key":"50_CR49","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1161\/01.STR.0000019910.90280.F1","volume":"33","author":"LP Kammersgaard","year":"2002","unstructured":"Kammersgaard LP, Jorgensen HS, Rungby RA, et al.: Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study. Stroke 2002, 33:1759\u20131762.","journal-title":"Stroke"},{"key":"50_CR50","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.STR.31.2.410","volume":"31","author":"C Hajat","year":"2000","unstructured":"Hajat C, Hajat S, Sharma P: Effects of post-stroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 2000, 31:410\u2013414. A rationale for the treatment of hypothermia in stroke patients.","journal-title":"Stroke"},{"key":"50_CR51","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/01.STR.0000126118.44249.5c","volume":"35","author":"DW Krieger","year":"2004","unstructured":"Krieger DW, Yenari MA: Therapeutic hypothermia for acute ischemic stroke. What do laboratory studies teach us? Stroke 2004, 35:1482\u20131489.","journal-title":"Stroke"},{"key":"50_CR52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3171\/jns.2004.100.2.0272","volume":"100","author":"H Wang","year":"2004","unstructured":"Wang H, Olivero W, Lanzino G, et al.: Rapid and selective cerebral hypothermia achieved using a cooling helmet. Neurosurg 2004, 100:272\u2013277.","journal-title":"Neurosurg"},{"key":"50_CR53","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/088307380001500511","volume":"15","author":"RJ Adams","year":"2000","unstructured":"Adams RJ: Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP). Child Neurol2000, 15:344\u2013349.","journal-title":"Child Neurol"},{"key":"50_CR54","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.110.5.924","volume":"110","author":"LV Gabis","year":"2002","unstructured":"Gabis LV, Yangala R, Lenn NJ: Time lag to diagnosis of stroke in children. Pediatrics 2002, 110:924\u2013928.","journal-title":"Pediatrics"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-005-0050-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-005-0050-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-005-0050-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:56:50Z","timestamp":1559422610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-005-0050-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["50"],"URL":"https:\/\/doi.org\/10.1007\/s11940-005-0050-y","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}